CDC: H1N1 vaccine supplies on the rise

NewsGuard 100/100 Score
"More than 22 million doses of swine flu vaccine are available now, and most Americans should soon find it easier to get their dose, U.S. health officials said Tuesday, " according to The Associated Press/The Washington Post.  "Last week there were just 14 million doses on hand, despite initial predictions that as many as 120 million would be ready by mid-October" an estimate the government was forced to reduce to 45 million, after manufacturing snags delayed vaccine output. "The slow supply trickle has frustrated Americans, who have stood in line for hours in some parts of the country" (Stobbe, 10/27).

In related news, "Two top senators overseeing the national response to the swine flu are sharply questioning the government's handling of the vaccination program, in one of the first indications that it could become a political issue for the Obama administration," The Wall Street Journal reports. "In a letter sent Tuesday to Kathleen Sebelius, secretary of Health and Human Services, Sens. Joseph Lieberman (I., Conn.) and Susan Collins (R., Maine) praised the government's initial steps on the H1N1 swine flu, but said they now have 'strong concerns' about the fallout from faulty estimates for how much vaccine would be available," according to the newspaper. "Unfortunately, these missteps in estimating available doses of H1N1 vaccine have effects beyond just growing public frustration; they have the potential to critically undermine our vaccine distribution efforts, which depend on accurate estimates of vaccine availability," the senators wrote. The letter requests that Sebelius "answer 13 questions, including when HHS knew that vaccine supplies would fall short of its projections, and why officials didn't narrow their list of target recipients to make sure those at highest risk got the limited supplies first" (McKay and Simpson, 10/28).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses